nedosiran
nedosiran: sourced relationships with 1 company · 2 clinical trials tracked.
nedosiran evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could nedosiran → DRNA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Dicerna Pharmaceuticals Inc (DRNA) Primary Hyperoxaluria; Primary Hyperoxaluria Type 1 (PH1) | Phase 2 |
Clinical Trial Registry Records (2)
Treatment of Primary Hyperoxaluria Type 1 With Nedosiran
A Phase 2 Open-Label Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nedosiran in Pediatric Patients From Birth to 11Years of Age With Primary Hyperoxaluria and Relatively Intact Renal Function
Primary endpoint: Percent Change From Baseline to Month 6 in Spot Urinary Oxalate-to-creatinine Ratio in PH1, PH2, or PH3 Participant Subgroups
Frequently asked questions
Which companies have sourced relationships with nedosiran?
nedosiran has dated SEC/FDA relationship records for Dicerna Pharmaceuticals Inc.
How many clinical trials involve nedosiran?
BioSniper tracks 2 clinical trials involving nedosiran.